Top Markets
Coin of the day
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
Pozycja w akcjach #41405
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Cena akcji
$0.0003
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$21.97K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
200.00%
Kraj
US
Handel MabCure Inc. (MBCI)

Kategoria

Historia ceny akcji dla MabCure Inc. (MBCI)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $1.01 dnia 2007-12-01
Historia cen akcji firmy MabCure Inc. od 2007 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 118.18%
2024 -66.67%
2023 -67.86%
2022 -77.94%
2021 91.39%
2020 243.41%
2019 -68.10%
2018 -32.65%
2017 14.91%
2016 75.25%
2015 -27.57%
2014 -62.58%
2013 -56.22%
2012 -85.27%
2011 -83.42%
2010 -14.01%
2009 -40.28%
2008 -0.99%
2007 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$59.08 62.03%
US
$49.75 72.45%
SE
$183.85 42.90%
FR
$62.63 5.31%
IT
$113.04 55.27%
US